aggressive LDL lowering and coronary plaque regression modified
A new study confirmed that very intensive lipid-lowering led to atherosclerotic plaque regression in patients who had not been on statins previously: see statin intensive plaque regression JAMANetwork2026 in dropbox, or doi:10.1001/jamacardio.2026.4788 Details: --this study was a prespecified analysis of the FLOWPROMOTE study, a randomized clinical trial performed in 3 Danish hospitals that had significant experience in conducting coronary CTA (coronary computed tomography angiography) as well as FFR-CT (flow fractional reserve) -- individuals were eligible to be included if they had coronary CTA >50% and FFR-CT <0.8 and had not been on chronic statins -- the initial coronary CTA at the time of diagnosis by was repeated at 9 and 18 months -- the goal of this study was to assess the association between achieved LDL cholesterol levels and atherosclerotic plaque regression -- this study was done from May 2020 to Oc...